[breadcrumb_custom]

Opko Health Inc (OPK) Stock’s Performance and Current Analyst Sentiments

In the latest trading session, 0.67 million Opko Health Inc (NASDAQ:OPK) shares changed hands as the company’s beta touched 1.82. With the company’s most recent per share price at $1.03 changed hands at -$0.02 or -1.43% at last look, the market valuation stands at $800.12M. OPK’s current price is a discount, trading about -117.48% off its 52-week high of $2.24. The share price had its 52-week low at $0.85, which suggests the last value was 17.48% up since then. When we look at Opko Health Inc’s average trading volume, we note the 10-day average is 8.19 million shares, with the 3-month average coming to 0.26.

Opko Health Inc (NASDAQ:OPK) trade information

Instantly OPK was in red as seen in intraday trades today. With action 6.43%, the performance over the past five days has been green. The drop to weekly highs of 1.0700 subtracted -1.43% to the stock’s daily price. The company’s shares are showing year-to-date downside of -31.46%, with the 5-day performance at 6.43% in the green. However, in the 30-day time frame, Opko Health Inc (NASDAQ:OPK) is 8.54% up. Looking at the short shares, we see there were 97.07 million shares sold at short interest cover period of 3.93 days.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Opko Health Inc (OPK) estimates and forecasts

Data shows that the Opko Health Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -42.82% over the past 6 months, a 30.56% in annual growth rate that is considerably higher than the industry average of 10.10%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2024 revenue estimates. The rating firms predict current quarter revenue for Opko Health Inc will rise 18.20%, while the growth in revenue is estimated to hit -200.00% for the next quarter. Year-over-year growth is forecast to reach -14.40% down from the last financial year.

Consensus estimates given by 6 financial analysts project the company’s revenue in the current quarter to hit an average of $177.53 million. 4 analysts are of the opinion that Opko Health Inc’s revenue for the quarter ending Mar 2024 will be $193.17 million. The company’s revenue for the corresponding quarters a year ago was $185.4 million and $237.6 million respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -4.20%. The estimates for the next quarter sales put growth at -18.70%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 3.51%. The 2024 estimates are for Opko Health Inc earnings to increase by 43.48%, but the outlook for the next 5-year period is at 12.00% per year.

On Key

Related Posts